Comparative Age-Based Prospective Multi-Institutional Observations from 12,367 Patients Enrolled to American College of Surgeons Oncology Group (ACOSOG Z901101) Trials (Alliance) Al-Refaie, Waddah B. , Decker, Paul A. , Ballman, Karla V. ... - - Ann. Surg. Oncol. - 2019 Manuscript - Secondary-not-in-original - Meta-Analysis - Older Adult - Z901101
Attributes and Outcomes of Older Adults in Surgical Oncology Trials: Results from ACOSOG Z901101 (Alliance) Al-Refaie, Waddah B. , Decker, Paul A. , Pisters, Peter W.T. ... - SSO - Ann. Surg. Oncol. - 2015 Abstract - Secondary-not-in-original - Comprehensive - Older Adult - Z901101
Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial Corless, Christopher L. , Ballman, Karla V. , Antonescu, Cristina R. ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - GI - ACOSOG-Z9001
Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor (GIST): ACOSOG Z9000 (Alliance) intergroup phase 2 trial DeMatteo, Ronald P. , Ballman, Karla V. , Antonescu, Cristina R. ... - - Ann. Surg. - 2013 Manuscript - Primary - Long-Term-Followup - GI - ACOSOG-Z9000
Placebo-Controlled Randomized Trial of Adjuvant Imatinib Mesylate Following the Resection of Localized, Primary Gastrointestinal Stromal Tumor (GIST) DeMatteo, Ronald P. , Ballman, Karla V. , Antonescu, Cristina R. ... - - Lancet - 2009 Manuscript - Primary - Primary - GI - ACOSOG-Z9001
